Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells.

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Abstract Text:

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Publishing Authors By Initials

For similar biological factors: biological markers: tumor markers, biological research abstracts see: biological factors: biological markers: tumor markers, biological research

PUBMED ID PMID:

MEDLINE DATE:

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Journal Published:

PUBLICATION TYPE: Letter

Journal: The British journal of ophthalmology

VOLUME: 90

Page Numbers: 801-2

Journal Abbreviation: Br J Ophthalmol

ISSN: 0007-1161

DAY: 28

MONTH: Jun

YEAR: 2006

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 421041

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Keywords Mesh Terms:

KEYWORDS: Tumor Markers, Biological

MESH TERMS: analysis

Chemical & Substance for Abstract: Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells. Information

Substance Name: Keratins

Registry Number: 68238-35-7

Grant and Affiliation Information for Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells.

AFFILIATION:

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Br J Ophthalmol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells Related Publications

• Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis.
• Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response.
• Cytokeratin subtyping to distinguish reactive and neoplastic RPE cells.
• Health services in four isolated districts in Nova Scotia.
• Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin).
• Human papillomavirus in pterygium.
• Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
• Neoplastic transformation of ciliary body epithelium is associated with loss of opticin expression.
• RIG-I has guts: identification of a role for RIG-I in colitis development.
• SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation.
• Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis.
• Temporal pterygium: benign or not?
• Ub Surprised: Viral Ovarian Tumor Domain Proteases Remove Ubiquitin and ISG15 Conjugates.
• Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.